June 26 (Reuters) - EMA:

* EMA - CHMP RECOMMENDED GRANTING MARKETING AUTHORISATION IN EU FOR KAFTRIO, FIRST TRIPLE COMBINATION THERAPY FOR TREATMENT OF CYSTIC FIBROSIS Source text for Eikon: Further company coverage: [ ]

Source: Reuters

Powered by NewsAPI.org